Human G protein-coupled receptor and modulators thereof for the treatment of atherosclerosis and atherosclerotic disease and for the treatment of conditions related to MCP-1 expression

Details for Australian Patent Application No. 2006284926 (hide)

Owner Arena Pharmaceuticals, Inc.

Inventors Gatlin, Joel; Unett, David J.; Hakak, Yaron; Liaw, Chen W.

Agent FB Rice

Pub. Number AU-A-2006284926

PCT Pub. Number WO2007/027661

Priority 60/714,137 02.09.05 US

Filing date 29 August 2006

Wipo publication date 8 March 2007

International Classifications

G01N 33/74 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving hormones

C07K 14/72 (2006.01) Peptides having more than 20 amino acids

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/027661 Priority application(s): WO2007/027661

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006284932-Media access control architecture

2006284922-Immunomodulating tumor necrosis factor receptor 25 (TNFR25) agonists, antagonists and immunotoxins